Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275–444. https://doi.org/10.1016/j.hrthm.2017.05.012.
Article PubMed PubMed Central Google Scholar
Hindricks G, Potpara T, Dagres N, ESC Scientific Document Group, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612.
Kuck KH, Brugada J, Fürnkranz A, FIRE AND ICE Investigators, et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016;374(23):2235–45. https://doi.org/10.1056/NEJMoa1602014.
Kuck KH, Albenque JP, Chun KJ, FIRE AND ICE Investigators, et al. Repeat ablation for atrial fibrillation recurrence post cryoballoon or radiofrequency ablation in the FIRE AND ICE trial. Circ Arrhythm Electrophysiol. 2019;12(6):e007247.
Article CAS PubMed Google Scholar
Njoku A, Kannabhiran M, Arora R, et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace. 2018;20(1):33–42.
Mohanty S, Della Rocca DG, Gianni C, et al. Predictors of recurrent atrial fibrillation following catheter ablation. Expert Rev Cardiovasc Ther. 2021;19(3):237–46. https://doi.org/10.1080/14779072.2021.1892490.
Article CAS PubMed Google Scholar
Osorio J, Hunter TD, Rajendra A, Zei P, Silverstein J, Morales G. Predictors of clinical success after paroxysmal atrial fibrillation catheter ablation. J Cardiovasc Electrophysiol. 2021;32(7):1814–21. https://doi.org/10.1111/jce.15028.
Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–72.
Padeletti L, Curnis A, Tondo C, et al. Pulmonary vein isolation with the cryoballoon technique: feasibility, procedural outcomes, and adoption in the real world: data from One Shot Technologies TO Pulmonary vein isolation (1STOP) Project. Pacing Clin Electrophysiol. 2017;40(1):46–56.
Tondo C, Iacopino S, Pieragnoli P, ClinicalService 1STOP Project Investigators, et al. Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: clinical outcomes from the real-world multicenter observational project. Heart Rhythm. 2018;15(3):363–8.
Letsas KP, Efremidis M, Giannopoulos G, et al. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Europace. 2014;16(2):202–7. https://doi.org/10.1093/europace/eut210.
Zhao J, Zhou D, Chen M, et al. CHA2DS2-VASc and SAMe-TT2R2 scores as predictors of recurrence for nonvalvular atrial fibrillation patients on vitamin K antagonists after radiofrequency catheter ablation. J Cardiovasc Med (Hagerstown). 2020;21(3):200–8. https://doi.org/10.2459/JCM.0000000000000930.
Jacobs V, May HT, Bair TL, et al. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Heart Rhythm. 2015;12(4):681–6. https://doi.org/10.1016/j.hrthm.2014.12.034.
Tu HT, Campbell BC, Meretoja A, et al. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Cerebrovasc Dis. 2013;36(4):273–80. https://doi.org/10.1159/000353670.
Article CAS PubMed Google Scholar
Kornej J, Hindricks G, Kosiuk J, et al. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Circ Arrhythm Electrophysiol. 2014;7(2):281–7. https://doi.org/10.1161/CIRCEP.113.001182.
Tsai CF, Huang PS, Chen JJ, et al. Correlation between CHA2DS2-VASc score and left atrial size in patients with atrial fibrillation: a more than 15-year prospective follow-up study. Front Cardiovasc Med. 2021;28(8): 653405. https://doi.org/10.3389/fcvm.2021.653405.
Daccarett M, Badger TJ, Akoum N, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57(7):831–8.
Article PubMed PubMed Central Google Scholar
Lohrmann G, Liu A, Ziegler P, Monteiro J, Varberg N, Passman R. CHA2DS2VASc score as a predictor of ablation success defined by continuous long-term monitoring. J Interv Card Electrophysiol. 2022;. https://doi.org/10.1007/s10840-022-01326-6. Online ahead of print.
Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311(5):498–506.
Article CAS PubMed Google Scholar
Demarchi A, Neumann L, Rordorf R, et al. Long-term outcome of catheter ablation for atrial fibrillation in patients with severe left atrial enlargement and reduced left ventricular ejection fraction. Europace. 2021;23(11):1751–2175.
Fortuni F, Casula M, Sanzo A, et al. Meta-analysis comparing cryoballoon versus radiofrequency as first ablation procedure for atrial fibrillation. Am J Cardiol. 2020;125(8):1170–9.
Rordorf R, Scazzuso F, Chun KRJ, Cryo AF global registry investigators, et al. Cryoballoon ablation for the treatment of atrial fibrillation in patients with concomitant heart failure and either reduced or preserved left ventricular ejection fraction: results from the Cryo AF Global Registry. J Am Heart Assoc. 2021;10(24):e021323.
留言 (0)